NCX 470

DRUG2 trials

Sponsors

Nicox Ophthalmics, Inc.

Conditions

Glaucoma, Open-AngleHypertension, OcularOpen Angle Glaucoma

Phase 2

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT03657797

Nicox Ophthalmics, Inc.Glaucoma, Open-Angle, Hypertension, Ocular

Start: 2018-08-01End: 2019-08-23Updated: 2023-06-18

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

CompletedNCT05938699

Nicox Ophthalmics, Inc.Open Angle Glaucoma

Start: 2023-12-12End: 2025-03-17Updated: 2025-09-08